These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7194660)
41. Mono- and bis-thiazolium salts have potent antimalarial activity. Hamzé A; Rubi E; Arnal P; Boisbrun M; Carcel C; Salom-Roig X; Maynadier M; Wein S; Vial H; Calas M J Med Chem; 2005 May; 48(10):3639-43. PubMed ID: 15887971 [TBL] [Abstract][Full Text] [Related]
42. Synthesis and antimalarial efficacy of aza-fused rhodacyanines in vitro and in the P. berghei mouse model. Takasu K; Pudhom K; Kaiser M; Brun R; Ihara M J Med Chem; 2006 Jul; 49(15):4795-8. PubMed ID: 16854088 [TBL] [Abstract][Full Text] [Related]
43. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Solomon VR; Puri SK; Srivastava K; Katti SB Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. Biot C; Glorian G; Maciejewski LA; Brocard JS J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235 [TBL] [Abstract][Full Text] [Related]
46. [Antimalarial 6-aminoquinolines, X: Further experiments on 2- and 4-hydroxymethyl derivatives (author's transl)]. Nickel P; Zimmermann R Arch Pharm (Weinheim); 1977 Jul; 310(7):537-43. PubMed ID: 901147 [No Abstract] [Full Text] [Related]
47. High antiplasmodial activity of novel plasmepsins I and II inhibitors. Dell'Agli M; Parapini S; Galli G; Vaiana N; Taramelli D; Sparatore A; Liu P; Dunn BM; Bosisio E; Romeo S J Med Chem; 2006 Dec; 49(25):7440-9. PubMed ID: 17149873 [TBL] [Abstract][Full Text] [Related]
48. [Studies on antimalarials. IX. Synthesis of 5-substituted phenoxy-6-methoxy-8-[(1-ethyl-4-aminobutyl) amino] quinolines]. Zhao DC; Zhang ZX; Shi YL; Ding DB; Wang SF; Yang JD; Guo BZ; Deng RX Yao Xue Xue Bao; 1984 Apr; 19(4):303-5. PubMed ID: 6496107 [No Abstract] [Full Text] [Related]
49. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro. Musonda CC; Little S; Yardley V; Chibale K Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333 [TBL] [Abstract][Full Text] [Related]
50. Amodiaquine analogs. Synthesis of 6-((3-(N,N-diethylamino)methyl-4-hydroxy)anilino)5,8-dimethoxy-2,4-dimethylquinoline and related compounds. Temple C; Rose JD; Montgomery JA J Med Chem; 1974 Sep; 17(9):972-7. PubMed ID: 4606204 [No Abstract] [Full Text] [Related]
51. Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol. Musonda CC; Gut J; Rosenthal PJ; Yardley V; Carvalho de Souza RC; Chibale K Bioorg Med Chem; 2006 Aug; 14(16):5605-15. PubMed ID: 16690319 [TBL] [Abstract][Full Text] [Related]
52. [Synthesis and study of the acute toxicity and antiparasitic activity on 6-nitro (amino)-4-dialkylaminoalkylaminoquinolines]. Bolotina LA; Bekhli AF; Lebedeva MN; Maksakovskaia EV; Naĭdenova AS Med Parazitol (Mosk); 1981; 50(2):51-4. PubMed ID: 7015098 [No Abstract] [Full Text] [Related]
53. Novel amodiaquine congeners as potent antimalarial agents. Casagrande M; Basilico N; Parapini S; Romeo S; Taramelli D; Sparatore A Bioorg Med Chem; 2008 Jul; 16(14):6813-23. PubMed ID: 18562202 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Chiyanzu I; Clarkson C; Smith PJ; Lehman J; Gut J; Rosenthal PJ; Chibale K Bioorg Med Chem; 2005 May; 13(9):3249-61. PubMed ID: 15809160 [TBL] [Abstract][Full Text] [Related]
55. [Possible carcinogenic activity of the Soviet antimalarial dabequin in a chronic experiment in animals]. Frol'tsova AE; Kharchenko NM; Lebedeva MN; Pylev LN Med Parazitol (Mosk); 1984; (6):6-13. PubMed ID: 6530977 [No Abstract] [Full Text] [Related]
56. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity. Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents. Vicente E; Lima LM; Bongard E; Charnaud S; Villar R; Solano B; Burguete A; Perez-Silanes S; Aldana I; Vivas L; Monge A Eur J Med Chem; 2008 Sep; 43(9):1903-10. PubMed ID: 18215443 [TBL] [Abstract][Full Text] [Related]
58. [Progress in the pharmaceutical chemistry of antimalarial agents during the last 2 decades]. Huang LS Yao Xue Xue Bao; 1983 Jul; 18(7):553-60. PubMed ID: 6606935 [No Abstract] [Full Text] [Related]
59. [Studies on antimalarials. I. Synthesis and antimalarial activities of some derivatives of 2,4-diamino-5-substituted amino pyrimidines and 2,4-diamino-6-methyl-5-substituted amino pyrimidines (author's transl)]. Zhang XP; Zhang XJ; Zheng XH; Chen L; Dai ZR Yao Xue Xue Bao; 1980 Dec; 15(12):711-8. PubMed ID: 7257796 [No Abstract] [Full Text] [Related]
60. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo. Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]